Shares in Titan Pharmaceuticals fall after Q3 miss

Shares in Titan Pharmaceuticals (NSDQ:TTNP) fell today after the company missed expectations on Wall Street with its third quarter results. The San Francisco, Calif.-based company posted a net loss of -$4.2 million on sales of $40,000 for the 3 months ended Sept. 30, for bottom-line loss of -60% on sales growth of 53.8% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Shares in Titan Pharmaceuticals fall after Q3 miss appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations MassDevice Earnings Roundup Pain Management Pharmaceuticals Wall Street Beat Titan Pharmaceuticals Source Type: news